Cornelia B. Landersdorfer

6.0k total citations · 1 hit paper
150 papers, 4.4k citations indexed

About

Cornelia B. Landersdorfer is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Cornelia B. Landersdorfer has authored 150 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Pharmacology, 82 papers in Molecular Medicine and 48 papers in Epidemiology. Recurrent topics in Cornelia B. Landersdorfer's work include Antibiotics Pharmacokinetics and Efficacy (98 papers), Antibiotic Resistance in Bacteria (82 papers) and Pneumonia and Respiratory Infections (36 papers). Cornelia B. Landersdorfer is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (98 papers), Antibiotic Resistance in Bacteria (82 papers) and Pneumonia and Respiratory Infections (36 papers). Cornelia B. Landersdorfer collaborates with scholars based in Australia, United States and Germany. Cornelia B. Landersdorfer's co-authors include Jürgen B. Bulitta, Roger L. Nation, Jian Li, Phillip J. Bergen, Ulrike Holzgrabe, Fritz Sörgel, Martina Kinzig, Alan Forrest, Akosua Adom Agyeman and Brian T. Tsuji and has published in prestigious journals such as Clinical Microbiology Reviews, Clinical Infectious Diseases and ACS Applied Materials & Interfaces.

In The Last Decade

Cornelia B. Landersdorfer

145 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis

2020 303 citations Akosua Adom Agyeman, Cornelia B. Landersdorfer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cornelia B. Landersdorfer Australia	36	2.3k	2.2k	1.2k	653	541	150	4.4k
William Couet France	36	1.6k 0.7×	1.8k 0.8×	980 0.8×	843 1.3×	233 0.4×	174	4.7k
Markus Zeitlinger Austria	41	1.2k 0.5×	2.5k 1.1×	1.5k 1.2×	790 1.2×	531 1.0×	340	6.9k
Manabu Inoue Japan	36	2.0k 0.9×	1.4k 0.6×	2.2k 1.8×	1.1k 1.6×	219 0.4×	146	5.0k
Christian Joukhadar Austria	40	865 0.4×	1.9k 0.9×	1.3k 1.1×	399 0.6×	223 0.4×	100	4.4k
J. M. Andrews United Kingdom	35	1.4k 0.6×	1.8k 0.8×	1.3k 1.0×	684 1.0×	199 0.4×	106	4.1k
Weiguo Liu United States	30	872 0.4×	1.3k 0.6×	960 0.8×	509 0.8×	211 0.4×	65	3.4k
Andrea Novelli Italy	34	744 0.3×	1.3k 0.6×	1.2k 1.0×	471 0.7×	249 0.5×	166	3.7k
Yun Cai China	31	1.3k 0.6×	808 0.4×	500 0.4×	1.3k 2.0×	310 0.6×	145	3.5k
J. Caillon France	32	759 0.3×	689 0.3×	1.0k 0.8×	608 0.9×	241 0.4×	192	3.4k
Sandrine Marchand France	28	1.1k 0.5×	1.3k 0.6×	758 0.6×	267 0.4×	176 0.3×	116	2.5k

Countries citing papers authored by Cornelia B. Landersdorfer

Since Specialization

Citations

This map shows the geographic impact of Cornelia B. Landersdorfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia B. Landersdorfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia B. Landersdorfer more than expected).

Fields of papers citing papers by Cornelia B. Landersdorfer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelia B. Landersdorfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia B. Landersdorfer. The network helps show where Cornelia B. Landersdorfer may publish in the future.

Co-authorship network of co-authors of Cornelia B. Landersdorfer

This figure shows the co-authorship network connecting the top 25 collaborators of Cornelia B. Landersdorfer. A scholar is included among the top collaborators of Cornelia B. Landersdorfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelia B. Landersdorfer. Cornelia B. Landersdorfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Wenhao, et al.. (2025). AI for NONMEM Coding in Pharmacometrics Research and Education: Shortcut or Pitfall?. CPT Pharmacometrics & Systems Pharmacology. 14(12). 1965–1969.

Zuegg, Johannes, Fabien Boeda, Cornelia B. Landersdorfer, et al.. (2025). Cyclic and linear cationic polymers based on metathesis polymerization for antibacterial and antifungal Applications. European Polymer Journal. 230. 113875–113875. 1 indexed citations

Chen, Nancy, Kenji Miyazawa, Miao Zhang, et al.. (2025). Clinical and Quantitative Pharmacology Considerations of mRNA Therapeutics and Vaccine Development: Bridging Translational and Platform Gaps for Enhanced Decision Making. Clinical Pharmacology & Therapeutics. 118(6). 1297–1312.

Horcajada, Juan Pablo, Ana Cristina Gales, Burcu Isler, et al.. (2025). Current and future options for the treatment of serious infections due to carbapenem-resistant Pseudomonas aeruginosa. Clinical Microbiology Reviews. 38(4). e0023324–e0023324.

Hussein, Maytham, Véronique Montembault, Laurent Fontaine, et al.. (2024). Providing insight into the mechanism of action of cationic lipidated oligomers using metabolomics. mSystems. 9(5). e0009324–e0009324.

Zhou, Jieqiang, Yuli Qian, Yinzhi Lang, et al.. (2024). Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial Agents and Chemotherapy. 68(3). e0139923–e0139923. 6 indexed citations

Agyeman, Akosua Adom, Carla López-Causapé, Kate E. Rogers, et al.. (2023). Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity. International Journal of Antimicrobial Agents. 62(3). 106887–106887. 10 indexed citations

Weiss, Anne, Robert J. Bischof, Cornelia B. Landersdorfer, et al.. (2023). Single-dose pharmacokinetics and lung function of nebulized niclosamide ethanolamine in sheep. Pharmaceutical Research. 40(8). 1915–1925. 3 indexed citations

Salim, Malinda, Andrew J. Clulow, Susanne Seibt, et al.. (2023). Construction of a Synthetic Colostrum Substitute and Its Protection of Intestinal Cells against Inflammation in an In Vitro Model of Necrotizing Enterocolitis. ACS Applied Materials & Interfaces. 15(30). 35847–35859. 1 indexed citations

10.

Bulitta, Jürgen B., Phillip J. Bergen, Yinzhi Lang, et al.. (2023). Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard Inocula. Journal of Pharmaceutical Sciences. 113(1). 202–213. 2 indexed citations

11.

Xu, Jing, Fuyi Li, Chen Li, et al.. (2023). iAMPCN: a deep-learning approach for identifying antimicrobial peptides and their functional activities. Briefings in Bioinformatics. 24(4). 58 indexed citations

12.

Abdallah, Mohammad, Cameron J. Nowell, John F. Quinn, et al.. (2023). Functionalisation of brush polyethylene glycol polymers with specific lipids extends their elimination half-life through association with natural lipid trafficking pathways. Acta Biomaterialia. 174. 191–205. 8 indexed citations

13.

Luterbach, Courtney, Hongqiang Qiu, Rajnikant Sharma, et al.. (2022). A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections. Antimicrobial Agents and Chemotherapy. 66(10). e0059122–e0059122. 12 indexed citations

14.

Rogers, Kate E., Yinzhi Lang, Tae‐Hwan Kim, et al.. (2022). Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model. Antibiotics. 11(1). 101–101. 4 indexed citations

15.

Daley, Andrew J., et al.. (2021). How important are MIC determination methods when targeting vancomycin levels in patients with Staphylococcus aureus infections?. Journal of Antimicrobial Chemotherapy. 76(6). 1641–1643. 2 indexed citations

16.

Bergen, Phillip J., Steven C. Wallis, Anton Y. Peleg, et al.. (2020). Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model. Antimicrobial Agents and Chemotherapy. 64(7). 11 indexed citations

17.

Bulitta, Jürgen B., et al.. (2019). Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling. Pharmaceutics. 11(9). 470–470. 5 indexed citations

18.

Lucas, Deanna Deveson, Carla López-Causapé, Yuling Huang, et al.. (2019). Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia. Antimicrobial Agents and Chemotherapy. 63(4). 63 indexed citations

19.

Yadav, Rajbharan, Phillip J. Bergen, Kate E. Rogers, et al.. (2019). Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients. Antimicrobial Agents and Chemotherapy. 64(1). 19 indexed citations

20.

Webster, Graham R., Jürgen B. Bulitta, Cornelia B. Landersdorfer, et al.. (2018). Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD). Drug Delivery and Translational Research. 8(3). 729–739. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact